MICHAEL SETH ALTMAN Transaction History

Date Transaction Value Shares Traded Form
Jul 31 2024
SELL
Sale (or disposition) back to the issuer
-
499,000
Mar 02 2021
BUY
Grant, award, or other acquisition
$4,990,000 $10.0 p/Share
499,000

Also insider at

NAUT
Nautilus Biotechnology, Inc. Healthcare
ARYE
ARYA Sciences Acquisition Corp V Financial Services
LYRA
Lyra Therapeutics, Inc. Healthcare
PCSC
Perceptive Capital Solutions Corp
MSA

Michael Seth Altman

Chief Financial Officer
New York, NY

Track Institutional and Insider Activities on ARYD

Follow ARYA Sciences Acquisition Corp IV and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARYD shares.

Notify only if

Insider Trading

Get notified when an Arya Sciences Acquisition Corp Iv insider buys or sells ARYD shares.

Notify only if

News

Receive news related to ARYA Sciences Acquisition Corp IV

Track Activities on ARYD